| MCVIX | VMVIX | MCVIX / VMVIX | |
| Total Expense Ratio | 0.72 | 0.19 | 379% |
| Annual Report Gross Expense Ratio | 0.73 | 0.19 | 384% |
| Fund Existence | 25 years | 20 years | - |
| Gain YTD | 13.306 | 13.622 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.2B | 37.2B | 46% |
| Annual Yield % from dividends | 1.28 | 1.76 | 73% |
| Returns for 1 year | 10.01 | 20.58 | 49% |
| Returns for 3 years | 21.64 | 43.50 | 50% |
| Returns for 5 years | 19.80 | 45.95 | 43% |
| Returns for 10 years | 88.29 | 123.25 | 72% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFIX | 18.74 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||
| VZICX | 38.53 | N/A | N/A |
| Vanguard International Core Stock Adm | |||
| SINAX | 43.65 | N/A | N/A |
| ClearBridge Large Cap Value A | |||
| KMKCX | 77.06 | N/A | N/A |
| Kinetics Market Opportunities Adv C | |||
| LICOX | 21.55 | N/A | N/A |
| Lord Abbett International Equity F3 | |||